Advisor Group Holdings, Inc. Abeona Therapeutics Inc. Put Options Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ABEO
# of Institutions
102Shares Held
31.6MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$18.4 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$12.9 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$11.2 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.6MShares$10.9 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$8.78 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $25M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...